FDA
approval
· 2022-11-17
FDA Approved: TZIELD — Original Application (Provention Bio, Inc.)
Summary
The FDA approved TZIELD (teplizumab-mzwv) in an original Biologics License Application to delay the onset of stage 3 type 1 diabetes in individuals at elevated …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TZIELD (TEPLIZUMAB-MZWV)